Star Therapeutics’ fundraise, investors punish Moderna’s stock, and more biotech news
Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27.
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Hi and hello from the Scripps Research Biotech Innovation Summit here in La Jolla.
Joy Jiao, head of life sciences research at OpenAI, said during her fireside: “I think it’s really only a matter of time before the models become superhuman at chemistry and biology … I really do think that’s going to happen in the next year or two and that’s what I find very exciting.”
STAT+ Exclusive Story
Already have an account? Log in
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in
To read the rest of this story subscribe to STAT+.
-
Meghana Keshavan covers biotech and contributes to The Readout newsletter.
